St. john of Jerusalem Eye Hospital
Company No: 3867950
Charity No: 1080185
ANNUAL REPORT
AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2024

Contents
Page
Legal and Administrative Information
Trustees, Report
Independent Auditors. Report
11
Statement of Financial Artivities
14
Income and Expenditure Account
14
Balance Sheet
15
Notes to the Financial Statements
16

Legal and Administrative Information
Registered and Principal Office
4 Charterhouse Mews
London ECIM 6BB
United Kingdom
Bankers
National Westminster Bank PIC
134 Aldersgate Street
London ECIA 4JB
United Kingdom
Bankers in the occupied Palestinian territories
Bank of Palestine PLC
Hebron Road
P.0. Box 765
Bethlehem
Independent Auditors
Pricewaterhousecoopers LLP
Savannah House, 3 Ocean Way,
Southampton S014 3TJ
United Kingdom

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
Introduction
Strategic Report
OUR STRATEGY 2023-2025
The Trustees present the Trustees, report
along with audited financial statements of SL
John of Jerusalem Eye Hospital (the
Company or SJJEH) for the year ended 31
December 2024. The financial statements
have been prepared in accordance with
Charities Act 2011, and with the Statement
of Recommended Practice: Accounting and
Reporting by Charities preparing their
accounts in accordance with the Financial
Reporting Standard applicable in the UK and
Republic of Ireland (FRS 102) and the UK
Companies Act 2006.
The 2023-2025 Strategic Plan was developed
through the collaborative efforts of the SJJEH'S
Board of Trustees, the senior management
team, and staff.
MISSION:
SJEH is a centre of excellence providing
ophthalmic care of high quality to the people
of the OPT regardless of ethnicity, religion,
social class, or ability to pay.
St. John of Jerusalem Eye Hospital was
formally incorporated as a private company
limited by guarantee in October 1999 under
the UK Companies House registration
number 3867950. Its MemoranduTn and
Articles of Association govern the Company.
It is registered as a UK charity having the
Charity Number 1080185.
VISION:
SJJEH will work to address avoidable blindness
in the OPT and be recognised as the leader in
the provision of quality eye care in the West
Bank, and the Gaza Strip.
The Charity's operations are centralised in
the Occupied Palestinian Territories where
it runs Day Hospitals in Hebron and Gaza,
and a Clinic in Anabta.
OUR STRATEGY IS CENTERED
ON OUR CORE VALUES:
Compassion:
Providing eye care with empathy and
willingness to promote wellbeing
Accountability:
Accepting responsibility for continuous
performance & improvement, embracing
change & seeking new opportunities to serve
Respect:
Honouring the dignity and diversity of each
person
Excellence:
Providing exceptionally high quality and
advanced care
Objects of the Charity
The Companys objects are the relief of
sickness and the
preservation
and
protection of health, in particular, but not
exclusively,
by
maintenance
and
development of St. Iohn Eye Hospital in the
Occupied Palestinian Territories (oPt) or
elsewhere and the clinical, teaching and
research activities connected therewith.

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
OUR STRATEGIC AIMS:
Our strategy outlines how we will
continue our mission through six
strategic aims..
SERVICES:
Provide eye care which is of the highest
quality, accessible and patient centred.
CLINICAL DEVELOPMENTS:
Lead ophthalmic education, research. and
innovation.
PEOPLE AND STAFF:
To be the employer of choice in our
community
TECHNOLOGY& DATA:
Integrate securetechnologyand
data governance with all core
asperts of the company s clinical
work.
GOOD GOVERNANCE & PARTNEILSHIPS:
Ensure the Group's good governance
and
strengthen
partnerships,
communications, and marketing locally
and worldwide.
FINANCES:
Ensure financiallysustainableservices.
It should be noted that our strategywas
developed prior to the current war in Gaza.
Much of what we had planned, especially in Gaza,
will be severely delayed by the current situation.

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
Review of the Year / Achievements and
Performance against Objectives
Gaza
treated which was over 9.500 outpatients
compared to 11,300 in 2023.
With the continuation of the war and the
displacement of the staff to the southern
parts of the Gaza Strip, the Hospital
remained nonfunctional in 2024. However,
the Board of Trustees approved a three-
phase medical intervention plan which
started in April 2024. Phase one, which
essentially focuses on the provision of
primary eye care services. commenced on
20th of April and phase two which focuses on
the treatment of Diabetic Retinopathy was
established in September 2024. We have
continued to face challenges in securing
medical supplies to Gaza including the
delivery oftwo LASER machines and regular
supply of Avastin injections. We continue to
work closely with the World Health
Organization and the Jordanian Royal
Hashemite Court to secure the delivery of
medical supplies, essential for phase two of
the plan.
Our Anabta Clinic is accessible for the I
rnillion residents in Anabta and surrounding
Nablus, Tulkarem and Jenin. Those living in
the area number amongst the poorest in the
oPt. Many of its residents are refugees from
Gaza, and it's easily accessible to many who
can't journey to our other services. There is
a particularly high prevalence of diabetic
retinopathy in this area of the West Bank
No major operation was undertaken at the
clinic during the year.
Hebron
Our Hebron Hospital is a vital source of eye
care in an area that is particularly affected by
the movement restrictions in the West Bank
The hospital provides sight-saving treatments
such as cataract and laser eye surgery to treat
diabetic retinopathy, and serves the 640,000
people who live in and around Hebron.
including the semi-nornadic Bedouins.
In total, and since April 2024, over 31,000
patients were treated in Gaza including 213
patients received sight saving intravitreal
Avastin injections and 159 diabetic patients
received LASER treatments.
Our Hospital treated over 15.800 (2023,
13.000) patients in 2024, including performing
654 (2023, 600) major operations.
Anabta
Financial Review
The clinic continues to operate on two floors
within the Red Crescent Society leased
premises.
The cost of the ongoing operations of the
Company in Gaza and the West Bank amounted
to £2.5m (2023. £3.9m), while total patient and
voluntary income amounted to £3.Im (2023,
£3.7m]. The overall net movement in funds was
a surplus of £0.7m (2023. £0.7m deficit)
In 2024, our Anabta clinic witnessed
another decrease in the number of patients

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
including exchange gains of £77k. The principal hospital in Nablus City. The total cost for this
component of operating costs (excluding the
project is estimated at circa £3million including
impairment loss) relates to personnel; 44%
(2023, 55%). The Company remains heavily
the cost to purchase the property. The project
dependent on voluntary incotne which. in the
was funded byThe Prioryin the USA ofThe Order
main, is obtained as a result of the fundraising
of St John, The David and Molly Pyott Foundation,
efforts of other Group companies.
The Australian Department of Foreign Affairs
Reserves
and Trade (DFATJ, and the Groups general
At 31 December 2024, reserves totalled £5,169k
reserves estimated at £1.2million. The project
(2023, E4.519k) including restrirted funds of
was completed in March 2025.
£49k (2023, £920k) leaving £5.120k (2023,
£3,599k) unrestrirted (comprising £3,170k in
tangible fixed assets and £1.950k in net current
assets). The Trustees review annually the need Working with Fred Hollows Foundation and
for reserves in line with the guidance issued by partners in Jordan, SJJEH has advanced plans to
the Charity Commission. In undertaking this
provide first aid mental health counselling for
review, the Trustees take into account general
our Gaza staff. We also plan to train a focal mental
reserves available elsewhere in the Group. The
health specialist/ counsellor in Gaza to deal with
Trustees recognise the need to maintain, as the
ongoing staff mental health issues.
circumstances allow, the level of general
reserves within the Company to ensure that it
SJJEH plans are highly influenced and will be
can continue to run efficiently with adequate
dictated, by the security situation on the ground.
working capital. This is intended to be achieved
We plan to:
through a renewed focus on cost-cuttin& A) Continue to provide outreach services at two
revenue generation, the introduction of new
locations in the south and middle of the Gaza
sources of revenue, and enhanced fundraising Strip.
activities to ensure financial resilience and
B) Strengthen our provisions of eye care in the
sustainability for the future. Thus. unrestrirted
North (currently working in two locations).
reserves need to be maintained to equate to at
C) Continue with phases one and two of the
least 18 months running costs (equivalent to
current plans.
£3.6m). The charity is maintaining higher levels
D) plan for renovation/restoration as the
of reserves as there are a number of current
Hospital building was found restorable following
political threats that have the potential to be
a comprehensive building survey that was
unresolved in the near future.
conducted in early 2025. This will require a
assive fundraising effort to raise sufficient
funding to restore, refurbish and re-equip the
hospital.
E) Renovate the Outpatient department first
before moving to the more complex facilities
Nablus Hospital
such as the operating theatres.
Due to the unstable political situation, movement
F) Approach the Palestinian Ministry of Health
restrictions and the continuous decline in the
and demand the retrieval of our equipment and
number of patients within our Anabta Clinic, the
Van taken by the ministry for safe keeping.
Board has approved a plan of relocating the
G) Coordinate with the Israeli Border Control
Authority to ship additional equipment and a
Anabta Clinic and the establishment of a new day generator to Gaza in anticipation for the
commencement of work at the Hospital.
Gaza Hospital
Plans for 2025

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
legacy giving in order to mitigate this risk as
well as a focus on major gifts for core costs.
No timeline can be determined to accomplish this
projert, which will be largely dependent on the
status of our building the availability of building Operationally. patient and staff access to
materials. movetnent of supplies across the
Jerusalem is crucial to the continuation of our
border, as well as available funding.
ability to provide eye care services in the
occupied Palestinian territories. Working in a
volatile region has inherent risks. Gaza has its
own risks. As is currently experienced and since
7th of October 2023, the situation could
escalate at any time as instability and strife
continues to affect the neighbouring countries, a
particular current concern.
Principal Risks & Uncertainties
Great emphasis continues to be placed covering
risk management - clinically. operationally and
financially.
A comprehensive risk management policy is in
place along with a risk register of all clinical,
operational, financial, external, political and
governance
risks.
The risk
register
is
continuously
reviewed by the
relevant
committees with particular focus on residual
risks.
The Clinical Governance Committee continues
its regular review of all medical and nursing
policies and protocols in addition to instigating
and reviewing clinical audits and investigating
clinical complications and 'near misses,.
The Board engages independent firms of
accountants to carry out internal audit
programmes on the financial controls in
operation within the CoMpan￿S activities.
A key risk which SJJEH faces continues to be
financial. The position has been exacerbated by
the political and economic uncertainties arising
in the areas that the charity operates can cause
volatility in the exchange rates for the
currencies the charity uses. The charity artively
monitors the likely movements in these
exchange rates and takes appropriate steps to
protect its assets and incotne. The position has
also been exacerbated by changes to the
statutory level of minimum wages and the
increased levels of inflation. SJJEH relies heavily
on voluntary income received mainly from
donors in the Middle East, Europe, the United
Kingdom and the United States. In the current
global financial situation, it remains a great
challenge to continue to attract core funding
from existing and new sources. The fundraising
strategy includes a focus on endowment and
Financial Risk Management
Liquidity is a recurring issue, especially with the
prolonged payment pattern of the Palestinian
Authority due to its operational needs. The
parent company i.e. the Group therefore sets
aside a portion of the investment portfolio as a
cash deposit, in order to ensure it will be able to
meet its operational needs.
International currency exchange movements are
an additional risk. Wherever possible purchasing
commitments are made to suppliers in the
currency of the source of funding for that
expenditure. which is usually US Dollars.

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
DIRECTORS, REPORT
changes. using a range of sources and taking
account of affordability.
Management consult with the finance. payroll
and remuneration, and HR committees of the
Board, and a pay review proposal is submitted to
the Board who makes the decision on the
proposal.
Fundraising Statement
SIJEH as a charity with income over £lm is
required to make a statement regarding its
fundraising artivities in accordance with the
Charities Act 2016. Fundraising activities are
carried out on behalf of SJJEH by our own in-
house fundraising staff and by volunteer
fundraisers.
We do not consider volunteer fundraisers to be
acting as legal representatives for the charity as
we have not formally contracted them to
fundraise on our behalf. Our small team of in-
house fundraising staff are fully trained on
fundraising regulations and have been made
aware of relevant policy procedures. We ensure
that we protect vulnerable persons from
unreasonable intrusion into their privacy.
persistent approaches or undue pressure to give
by using a personal approach to fundraising.
We do not use professional fundraisers or
commercial participators in any of our activities
and we are registered with the Fundraising Our Annual Report sets out our artivities,
Regulator. No complaints were received by SIJEH
achievements and performance during the year,
in relation to its fundraising during the relevant
which are directly related to the objects and
period and, after due enquiry, we are not aware
purposes for which SIJEH exists. SJIEH achieves
of any breaches of the regulations of the
its principal objertives through the delivery of
Fundraising Regulator committed by SJJEH.
services to members of the public in the West
Bank and Gaza without regard for any distinction
by race, c13ss or religion.
Future Developments and
Financial Risk Management
Future developments and financial risk
tnanagement and exposure to financial risks are
detailed in the Strategic Report.
Public Benefit
The Trustees have given due regard to the
Charity Commission's General Guidance on
public benefit when planning the charity's
activities.
Remuneration policy
The Public Benefit from SJJEH'S
activities is:
All roles within the Company are evaluated in
order to determine where it fits on our pay scale.
The salaries within the scale are determined by
the market rates for an equivalent position. In
exceptional cases, where the market information
supports it, salaries may be above the top of the
band. Each year, the payroll budget is reviewed,
based on legislative, statutory and market
the provision and development of clinical
and surgical ophthalmic services to patients
at the Hebron & Gaza Hospitals and the clinic
in Anabta:

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
the exemption from charge when the
relevant authority does not finance the
treatment and the patient is unable to pay all
or part thetnselves;
the teaching and training artivities at the
Hospitals which enhance the quality of
service delivered and also increase the pool
of qualified ophthalmologists, specialist
nurses and allied healthcare professionals
within the region;
the research activities into endemic diseases
affecting the Palestinian population; and
our services enhance education and
employment prospects and contribute to
economic growth.
Further details of the above are set out in Note I
to the Financial Statements.
Having assessed the combination of all these
various matters. and a written agreement from
the Group to provide such financial support as is
required to enable the Company to fulfil all of its
obligations as they fall due, the Board of Trustees
have a reasonable expectation that SJJEH has
adequate resources to continue in operational
existence for the period to December 2026, being
a period of at least 12 months from the date of
approval of the financial statements.
For these reasons, the Board of Trustees have
adopted the going concern basis of preparation
the
financial
statements.
Going concern
Governance and Management
The sole member ofthe Company, since 31 March
The Trustees must satisfy themselves as to
2011. is SL John of Ierusalem Eye Hospital Group,
SIIEH'S ability to continue as a going concern for
(the Group) which appoints the Board of
a minimum period of 12 months from the date of
approval of the financial statements.
Directors/Trustees of the Company (the Board).
The Trustees have produced detailed, yet
The Board manages the business and affairs of
adaptable, business plans that consider SJJEH'S
the Company and usually meets three times a
forecast and projected activity. the related year. At its meetings, the Board reviews the
financial budgets, cash flows and liquidity for the
performance of the Company and, in particular,
period to December 2026.
the performance of the hospitals in Gaza and
The Trustees have also considered in their
Hebron, and the clinic in Anabta. The Board also
assessment of going concern the impart of a
challenging, yet reasonably plausible. downside
considers and approves the operational and
scenario (sensitivity analysis) on the Company's
capital budgets. The Steering Committee meets
liquidity position. Under this scenario, SJIEH
three times a year between the three Board
projerts to have sufficient liquidity through the
rneetings to maintain momentum on Board
period to December 2026.
matters between meetings.
Nevertheless, the Trustees have sought to
identify certain mitigating artions that could be
implemented, in order to provide additional
liquidity or reduce cash outflows, so as to ensure
that SJJEH can maintain sufficient liquidity over
the period to December 2026
maintaining a
balance between supporting the activity that is
crucial to delivering the objerts of the charity,
whilst
ensuring the
long-term financial
sustainability of SJJEH.
The Board is aware of the codification of
Directors. duties under the Companies Act 2006
and takes these duties into account in
consideration of SJJEH'S activities.
New Trustees are selected in consultation with
the Board to maintain an appropriate balance of
skills, experience and diversity. Trustees are
appointed for a term of three years and may be
reappointed for two further terms of three years

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
and are not normally eligible for a further
reappointment. An induction programme is in
place for new dirertors.
The Board currently has the following
Committees:
The Board appoints the Chief Executive who
reports to the Chairman and is accountable to the
Board. The Chief Executive is Dr. Ahm3d Ma'ali,
appointed from May 2019.
Steering Committee
Finance Committee.
Investment Committee
Audit Committee,
Fundraisin& Marketing & Communication
Committee
Strategy and Planning Con]mittee
Clinical Governance Committee
Honours and Awards Committee.
Payroll and Remuneration Committee
Human Resources Committee
Guild Liaison
Digital and IT Committee
The Trustees, who are also the dirertors for the
purpose of UK company law, during the year
and at the date of this report, are listed below:
Sir Andrew Cash (Chairman)
Mr. C. Hoult (Treasurer and Cornpany
Secretary)
Miss. H. Dodds (Forsyth)
Mr. P. Hackwood
Mrs. A. Bhatia
Ms. l. Levin
"Non-trustees are appointed to these committees
Dr. M.
Abu-Ramadan (reappointed for their expertise.
January 2024: resigned l April 2024)
Dr D.H. Verity
Mr. J. Ingham Clark
Mr. J Macaskill
Mr. T. Jones
Mr. D.E.I Pyott
Ms D. Corner (resigned 30 November 2024)
Mr. J von Einem
Ms H. Winterton (appointed November
2024)
Each committee has terms of reference, which
were updated in 2024.
Charity Trustee Indemnity insurance is provided
at a cost of £12,699 [2023, £13,433) to cover the
charity. trustees and officers against potential
claims and losses.

SL John of Jerusalem Eye Hospital
Trustees. Report
For the year ended 31 December 2024
Statement of Trustees,
Responsibilities
The Trustees (who are also directors of St. John
of Jerusalem Eye Hospital for the purposes of
company law) are responsible for preparing the
Trustees, Annual Report and the financial
statements in accordance with applicable law
and regulation.
to show and explain the charitable company s
transactions and disclose with reasonable
accurary at any time the financial position of the
charitable company and enable them to ensure
that the financial statements comply with the
Companies Act 2006. They are also responsible
for safeguarding the assets of the charitable
company and hence for taking reasonable steps
for the prevention and detection of fraud and
other irregularities.
Company law requires the Trustees to prepare
financial statements for each financial year.
Under that law the Trustees have prepared the
financial statements in accordance with United
Kingdom Accounting Standards. comprising FRS The
Trustees
are
responsible
for the
102 "The Financial Reporting Standard
maintenance and integrity of the charitable
applicable in the UK and Republic of Ireland", and
companys website. Legislation in the United
applicable law (United Kingdom Generally
Kingdom governing the preparation and
Accepted Accounting Practice).
dissemination of financial statements may differ
Under company law the Trustees must not
from legislation in other jurisdictions.
approve the financial statements unless they are
satisfied that they give a true and fair view of the
In so far as the Trustees are aware at the time of
state of the affairs of the charitable company and
approving our Trustees. Annual Report:
of the incoming resources and application of (a) there is no relevant audit information of
resources, including the income and expenditure,
which the company's auditors are unaware; and
of the charitable company for that period. In
(b) the Trustees have taken all the steps that they
preparing these financial statements, the
ought to have taken as Trustees in order to make
Trustees are required to:
themselves aware of any relevant audit
select suitable accounting policies and then
information and to establish that the company s
apply them consistently:
auditors are aware of that information.
observe the methods and principles in the
Statement
Recommended
Practice:
Accounting and Reporting by Charities:
make judgments and estimates that are
reasonable and prudent;
state whether FRS 102 "The Financial
Reporting Standard applicable in the UK and
Republic of Ireland" has been followed, subject to
any material departures disclosed and explained
in the financial statements,. and
prepare the financial statements on the going
concern basis unless it is inappropriate to
presume that the charitable company will
continue in business.
The Trustees are responsible for keeping
adequate accounting records that are sufficient
The Trustees, Report (including the Strategic
Report) on pages 2 to 10 was approved by the
Trustees and signed on their behalf by:
Sir Andrew Cash
Chairman, Board of Trustees,
St. John of Jerusalem Eye Hospital
Company No. 3867950
Date:04108/2025
io

Independent Auditors. Report to the Members
of SL John of Jerusalem Eye Hospital
Report on the audit of the
financial statements
least twelve months from the date on which the
financial statements are authorised for issue.
In auditing the financial statements, we have
concluded that the trustees, use of the going concern
basis of accounting in the preparation of the financial
statements is appropriate.
Opinion
In OUT opinion, St. John of Jerusalen] Eye Hospital's
financial statements (the "financial statements"):
give a true and fair iqeiy of the state of the
charitable company's affairs as at 31 December 2024
and of its incoming resources and application of
resources, including its income and expenditure, for
the year then ended.
have been properly prepared in accordance
Mqth United Kingdom Generally Accepted Aceoiinting
Practice (United Kingdom Accounting Standards,
ineluding FRS 102 "The Financial Reporting Standard
applicable in the UK and Republic of Ireland",
applicable law). and
have been prepared in accordance with the
requirements of the Ci)mpanies Aet 2006.
We have audited the financial statetnents, ineliided
Mrythin the Annual Report and Finaneial Statements
(the "Annual Report"), Ivhieh eompri.8e: the Balanee
Sheet as at 31 Deeerllber 2024; the Statement of
Financial Actiiqties
(including
income
and
expenditure accoiint) for the }'ear then ended" and the
notes to the financial statements. which include a
description of significant accounting policies.
However, because not all future events or Conditions
can be predicted, this conclusion is not a guarantee as
to the eharitable COMpan￿S ability to continue as a
going concern.
Our responsibilities and the responsibilities of the
trustees with respect to going concern are described in
the relevant sections of this report.
Reporting on other information
The otherinforniation comprises all of the information
in the Annual Report other than the financial
statements and our auditors, report thereon. The
trustees are responsible for the other information. Our
opinion on the financial statements does not cover the
other information and, accordinglj, we do not express
an audit opinion or, except to the extent otheThwe
explicitl}' stated in this report, any forni of assurance
thereon.
Basisfor opinion
In connection Mryth our audit of the financial
statetnents, our responsibility is to read the other
infornation and, in doing so, Consider M,hether the
other information is materially inconsistent with the
financial statements or our knowledge obtained in the
audit, or otherhryse appears to be materially misstated.
If we identify, an apparent material inconsistency or
materia] misstatement, MTe are required to perform
proeedures to conclude whether there is a material
misststement of the financial statements or a material
mi&statement of the other inforn]ation. If, based on the
York we haiTe perfornied, we conclude that there is a
material misstatement of this other information, we
are required to report that fact. We have nothing to
report based on these responsibilities.
We conducted our audit in accordance with
International Standards on Auditing (UK) ("ISAs
(UK)") and applicablc law. OUT responsibilities under
ISAS (UK) are further described in the Auditors.
responsibilities for the audit of the financial
statements seetion of our report. We beliei e that the
audit eNqdence we haN'e obtained is sufficient and
appropriate to provide a basis for our opinion.
Independence
We remained independent of the charitable company
in accordance with the ethical requirements that are
releTr"ant to our audit of the financial statements in the
UK, which includes the FRC'S Ethical Standard and li'e
have fulfilled our other ethical responsibilities in
accordance with these requirements.
Conclusions relating to going concern
With respect to Strategic Report and Trustees, Report,
ive also considered whether the disclosures required
by the UK Companies Act 2006 and Charities Act 2011
have been included.
Based on the work we have perforn]ed, M'e hal'e not
identified any material uncertainties relating to eN"ents
or conditions that, individuallv or collectii'ely, may
cast significant doubt on the charitable company's
ability to continue as a going concern for a period of at
Based on our work undertaken in the course of the
audit, the Companies Act 2006 requires us also to
report certain opinions and matters as described
below.
li

Independent Auditors. Report to the Members
of SL John of Jerusalem Eye Hospital
Strategic Report and r￿￿tees'Rep0rt
Irregularities, including fraud, are instances of non-
compliance ivith laws and regulations. We design
procedures in line ￿th our responsibilities, outlined
aboiye, to detect material misstatements in respect of
irregularities, including fraud. The extent to which our
procedures are capable of detecting irregularities,
including fraud. is detailed below.
Based on our understanding of the charitable company
and its industry'/eni'ironment, Ive identified that the
principal risks of non-compliance with laws and
regulations related to the Companies Act 2006 and the
Charities Act 2011, and we considered the extent to
vhich non-compliance might have a material effect on
the financial statetnents. We also considered the direct
impact of these laN¥s and regulations on the financial
statements. We evaluated management's incentives
and opportunities for fraudulent manipulation of the
financial statements (including the risk of override of
controls), and detertnined that the principal risks were
As explained more full}. in the Statement of T￿￿tees.
related to posting of inappropriate journal entries and
Responsibilities, the trustees (who are also the
manipulation of key accounting judgements and
directors of the charitable eompanv forthe purposes of
estimates. Audit procedures performed by the
company law) are responsible for the preparation of
engagement team included:
the financial statements in accordance V*ith the
Testing journal entries where we identified partieular
applicable frameThork and for being satisfied that they fraud risk eriteria.
give a true and fair view. The t￿￿teeS are also
responsible for such internal control as they deterniine
Testing estimates and judgements made in the
is necessary to enable the preparation of financial
preparation of the financial statements for indieators
statements that are free from material misstatement.
of bias.
whether due to fraud or error.
In our opinion, based on the work undertaken in the
course of the audit the infonnation gii'en in the
Strategie Report and the Trustees, Report for the year
ended 31 December 2024 is consistent with the
financial statements and has been prepared in
accordance with applicable legal requirements.
In light of the knowledge and understsnding of the
charitable company and its eniironment obtained in
the course of the audit, we did not identify any material
misstatements in the Strategic Report and the
Trustees, Report.
Responsibilitiesfor thefinancial statements and
the audit
Responsibilities of the trusteesfor thefinancial
StateTnent5
Keiiewing minutes of meetings of the Board of
Trustees and Board subcommittees, and reTrTieMing the
terms and conditions of significant contracts and
agreements.
Holding discllssions with the trllstees and
management to identty significant or unusual
transactions and knoMry] or suspeeted instances of
fraud or non-compliance applicable laws and
regulations.
Assessing financial statement disclosures, and
agreeing these to supporting evidence, for compliance
with applicable and regulations.
There are inherent limitations in the audit procedures
described aboi'e. We are less likely to become aware of
instances of non-compliance with laws and regulations
that are not closely related to eirents and transactions
reflected in financial statements. Also, the risk of not
detecting a material misstatement due to fraud is
higherthan the risk of not detecting one resulting from
error, as fraiid may iniToIN"e deliberate concealment by,
for example, forger5' or intentional misrepresentations
or through collusion.
A further description of our responsibilities for the
audit of the financial statements is located on the
In preparing the financial statements, the trustees are
responsible for assessing the charitable cotnpanvs
ability to continue as a going concern, disclosing, as
applicable, matters related to going concern and using
the going concern basis of accounting unless the
trustees either intend to liquidate the charitable
companN" or to cease operations, or haTr'e no realistic
alternative but to do so.
Auditors, responsibilitiesfor the audit of the
financial statements
Our objectives are to obtain reasonable assurance
about whether the financial statements as a whole are
free from material misstatement, whether due to fraud
or error, and to issue an aiiditors, report that includes
our opinion. Reasonable assurance is a high level of
assurance, but is not a guarantee that an audit
conducted in accordan￿ with ISAS (UK) will alivajs
detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate,
they could reasonably be expected to influence the
economic decisions of users taken on the basis of these
financial statements.
12

## **Independent Auditors' Report to the Members of St. John of Jerusalem Eye Hospital** 

FRC's website at: www .frc.org. uk/ a uditorsresponsibilities. This description forms part of our auditors' report. 

_Use of this report_ 

This report, including the opinions, has been prepared for and only for the charitable company's members as a body in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and for no other purpose. We do not, in giving these opinions, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. 

## **Other required reporting** 

## _**Companies Act 2006 exception reporting**_ 

Under the Companies Act 2006 we are required to report to you if, in our opinion: 

• we have not obtained all the information and explanations we require for our audit; or 

• adequate accounting records have not been kept by the charitable company, or returns adequate for our audit have not been received from branches not visited by us; or 

• certain disclosures of trustees' remuneration specified by law are not made; or 

• the charitable company financial statements are not in agreement with the accounting records and returns. 

We have no exceptions to report arising from this responsibility 

Sasha Lewis (Senior Statutory Auditor) For and on behalf of PricewaterhouseCoopers LLP Chartered Accountants and Statutory Auditors Southampton Date: 08 August 2025 

13 



## **St. John of Jerusalem Eye Hospital Statement of Financial Activities (including income and expenditure account) For the year ended 31 December 2024** 

|**Unrestricted**<br>**Restricted**<br>**Total**<br>**Total**|
|---|
|**Funds**<br>**Funds**<br>**Funds**<br>**Funds**|
|**2024**<br>**2024**<br>**2024**<br>**2023**|
|**Notes**<br>**£'000**<br>**£'000**<br>**£'000**<br>**£'000**<br>E~~EE~~<br>~~ws.~~<br>~~Am Owme-.q_<wewrr~~<br>~~oO~~<br>~~“"m~~<br>~~—~~|
|**Income**|
|Income from donations and legacies<br>3<br>47<br>2,455<br>2,502<br>2,245|
|Income from charitable activities<br>4<br>586<br>586<br>**Total income**<br>**633**<br>**2 455**<br>**3,088**<br>1,486<br>**3,731**<br>ee<br>~~ah~~|
|**Expenditure**|
|Expenditure on charitable activities<br>(302)<br>(2,196)<br>(2,498)<br>(3,909)|
|Governance and Other expenditure<br>(17)<br>(17)<br>**Total expenditure**<br>5<br>**(319)**<br>**(2,196)**<br>**(2,515)**<br>(17)<br>**(3,926)**<br>eee<br>SCCMCh<br>ooo<br>SOOO|
|**Net income/ (expenditure)**<br>314<br>259<br>573<br>(195)|
|Transfers between funds<br>10, 11<br>1,130<br>{1,130)|
|Exchange gains/(losses) on overseas activities<br>77<br>77<br>(501)|
|**Net Movement in Funds**<br>**1,521**<br>**{871}**<br>**650**<br>**{696}**<br>—————<br>~~Sr~~<br>EEE ————E|
|Fund balances brought forward at 1 January<br>3,599<br>920<br>4,519<br>5,215|
|**Fund balances carried forward at 31 December**<br>12<br>**5,120**<br>**49**<br>**5!169**<br>**4,519**<br>~~SSS~~<br>SSS<br>SOOO|



All gains and losses recognised in the year are included in the Statement of Financial Activities. All of the above results are derived from continuing activities. 

The accounting policies and the notes on pages 16 to 24 form part of these financial statements. 

14 



## **St. John of Jerusalem Eye Hospital Company 3867950 Balance Sheet as at 31 December 2024** 

||**Note**|**2024**|**2024**|**2023**|
|---|---|---|---|---|
|||**£'000**||**£'000**|
|**Fixed Assets**|||||
|Tangible assets|7||3,170|2,592|
|TotalFixed Assets|||3170|2 592|
|**Current Assets**|||||
|Debtors|8||1,974|2,704|
|Cash at bank and in hand|||1,895|2,500|
|Total Current Assets|||3,869|5,204|
|Creditors: Amounts falling due within|||||
|one year|9||(1,870)|(3,277)|
|**Net Current Assets**|||1,999|1,927|
|**Total Assets Less Current Liabilities**|||5,169|4,519|
|**Net Assets**<br>**5169**<br>**4 519**<br>Se<br>—————a|||||
|**The Funds of the Charity**|||||
|Restricted income funds|10||49|920|
|Unrestrictedincomefunds|11||5,120|3,599|
|**Total Charity Funds**<br>12<br>**5169**<br>**4 519**<br>eee<br>ee<br>eee|||||



The accounting policies and the notes on pages 16 to 24 form part of these financial statements. The financial statements on pages 14 to 24 were approved by the Trustees and signed on their behalf by: 

## _**c.-J**_ 

.. ... , .. ,,. ,, .... Sir Andrew Cash Chairman, Board of Trustees 

. .. Christopher Hoult Treasurer 

Date: 04/08/2025 

15 



SL John of J•rusalem Eye Hospitsl
Notss to the Flnan¢lal Ststements
Forthe y￿r ended 31 Lkn•mber 2024
1 Prtn¢ip•l •ccourrttng puli¢t•8
• Basls ol preparation
The finanual statsments of St. John d Jerttsakm E)* H*1 l the fhaw or ts'CorrF4rf) the goNy4 cDr¢em b*¢,
under the hBlorical cc61 cofftntK)n. at tra￿ ￿k)e un*$ otWe the reèwdnt Jotelsl 10 these
financial ststements. The fill￿al ststewts Iwt tttn wet* in *ith the SlaiThnt of Prth appsub￿ to
tharite5 kxepariNJ Iheir ￿Unts in arLord8rte the Fin￿& Statsd appk&k in the UK and of IreW SORP
IFRS 1021.1, thè Fllianc￿ Rewts"vJ aF￿￿th ￿ Ihe UK of Ir*ThJ rFRS ior), the cb8r11￿ 2011 and Ccthpan*s
Act 2OA.
Th8 G)mpanl8 obfr¥ts ere Ihe r*f of and thtt [Nk%er￿A￿ Dfh8dth. in Fgrkuk. not gxcktsith. ty rrinlen3nr£
dèvelopNnt ol St. John Eye FthWI in clxu￿d P*knk4n TpJritw and the din￿. teatslry res&¥ch act'wk5 ￿n￿led
IherEwllti.
¢ompany ts exemoed from preparing c#￿)fyJknn under FRS I￿2 Para3￿ 9.9 (COMpw￿ +lcl Th 5401. The ulbffAi8 parent undertakir
and eontrdliro paty o St. J)hn of E>p Hoswia GrDUP1th6 'Gr￿p.1, a ojmpany inrorwrth in lh8 United King(SDm under regi8tration
numb6r 7355619. It is w¥tsred as a chwity underthe num￿ 1139527 has a regLSt¥&l (Jfrè a 4 Ch*t6th)use m￿3. Londrm. EC1M 68B.
St John of jeruSa￿M Eye Hosprt* (knp $ fv pareni uTrJenakiro of the STr@Me5t aryl Wgest grwp d uThJeffdkn"ry to these fjnano
ststements at 31 Oeofftlw 2024. The consdthbl of ol Eje Gr￿P are frcrfn 4
Ch8rterhcA￿e m*￿. London. EC1M 68B.
Going Concern
BACKGROUND
In 3ssesswKJ thÈ concem p￿rtb)n ol Charity. the TDJsle8s wrmlucd deta￿, knirw • Ihat ct)nsider the Chariys
lorecasl and prt>pded the TrLated Wets. cth Iv4u￿ty ts the ￿¥j to D￿er[thr 2026. whth ￿ a ol at èast
12 monlhs fr(wn the date of approv￿ of the fnanCl￿ sta*nts.
This assessm￿1 t*rK*J was s*¢tsd as it akJns to the Charivs fooKi* wK1, s *)th ts p￿55 bmdines and ts a
pemd ol at least12 months from the dyte c1wro￿l0fthefi[W￿ stste1T￿ts.
vn IIY4 Clrdrlyb Ld&li TIWi￿ gt¥y in pEparir9 finanud
ststements.
KEY ASSUfvIPnONS
The bu￿ne$S and fin8nr4 Fkn fftts)rpy3tè the a5S
. Demand for servres from patEDts ttE catw arKJ suppty of Ftht sme5 ty the GTDUP is bl￿ge￿I l(K Ihe saffe ol acti¥ty durry
2024 due to thè ￿rnnt urffjtsbk aThJ sfxur1tysitLk3b￿ r*JvM. No irKoTh is a￿un￿j kn te recewl IrDm Gaza durng 2025.
. Payw*nt by the Paesknkin IPA) Idiredty, or ￿￿"r• ts tmn lU￿1¥j S￿[ces) d suifrwt p*rnts tothe Grwg for pthl seNices
provided.
.The athwewlof a r￿u¢l￿]n in thrcujh the rEStrth"rg oflk
. The Charty onic•yJ ¥clthtsry aThJ luTrJrai%y¥J l￿B￿tr￿
SENSlnlnTY ANALYSIS
The Trnstees have consthA the l¢ywzst arKJ tmo￿ tht£s. b￿￿jets. c& *Ju￿rtY of 8 Chall￿1T#J, yEt
pbusibb, doWn￿e sc*nario Isem￿Vty anty￿) such thatthe key wur[￿ts￿ &e mt nrt orth io Le nrt ll) whc* cf
Thi8 compllses..
.Fladuced patiwtdemarKI cap8Dtysuppty of3ervw aTrJ ckAurn Gaza Hc4Frta.
.RwJu(*d ofwJ￿n￿and fundraBwvJ UFbres1￿* irwre.
.Incroase in mininum end hw3her of inllathx ￿ pa￿?11 malwiak, and h9hgrerwgy casts.
Under thK3 5GerFa￿. the C￿rity pro￿(￿$ to Iv4uTrJty thwh the PWiDd to Do¢wt¢r 2028. ￿th￿l n88thThJ to
Nevetheless, tr* Trust￿ sothJhl io thntfy c*n rrÈlvJathig Ihat te implwted, in c(thr to mvJe ￿qU￿￿ty
redurs rash out￿￿$. so asto ￿ksure that the Ghwitycan rromtsin suffvxnt kuvjty owthe to D￿l[￿r2D26.
CONCLUSIONS
Having w*sed Ihe wnbnation ol all these Y*1¢￿ aTrJ a written ￿ree￿I IrNn the Group to such finar4ci81 support as
req￿red b enabl8 the Company to 11 ot ts OtrAgat￿￿ as Irw f￿1 ￿e, th& TrL*W twe a reasonabb &KF￿a￿)n thai the Charlty ha5
uate resour￿ lo ￿ts"nue in oFuatKJrol exists￿e ￿ the pw¥)J tr) 2026. of a *asi 12 n¥Jths fM the date ol
approval olthefin8ncBI 5fat8n￿ts.
Accordj'ngty, thesè financial Stat￿nts do rol any •Jpthwits to the wir#J ass6ts aThJ1otrpJthes that w(
resutt rf the Chanty wpje tocCfitmL￿a1 a G
16

SL John of Jerusalem Eye Hospftal
Notes to the Financial Statements
For the year ended 31 December 2024
1 Principal accounting policies (continued)
b Foreign currencies
The Charitys functional currerw is New Israeli Shekels. Tranwtions in foreign currencies are recorded at
exchange rale ruling at the date of the transaction. Monetsry assets and liabilities 31 the year end are translated at
the rate ruling at the balance sheet date. The pres8ntational cutterty is pjunds sterting and results are translated at
the average rate for the period and assets and liabilibes at the balan￿ sheet rale. All exchange differences are deat
in the Statement of Financial Actsvities. Exchange dtfferences on the translation of functional currency into the
presentational cuffency are included as other recognised gains and losses. All other exchange differences are
included as incoming resources or resources expended as appropriate. The exchange rate of the Pounds Sterling to
the15fdeli Shekel at 2024 year*nd was 4.574312023, 4.6209), while the averaJe rdte for 2024 was 4.728812023,
4.58561.
c Income recognition
Donations and other income are rewJnised in the finawal statements on a re￿1¥able basis. Grants are recc¥Jnised
when the entitlement lo the grant is confimed. Legacies are recognised ￿ the entidement arises, being the earti@r
of the Charity being notified of the impending disln'bution or the legacy being received.Donations in kind are recorded
as income when the ￿SOurceS are r￿1Ved and recorded at fair value. Income from charÈtable activities is accounted
for when eamed i.e. the se￿￿ is provided to patients. Subsyjies and exemptions in respect of medical seNi
provided without charge are shown as a deduction from gross income.
d Volunteers
The value of services rendered by medical volunteers is not recc*Jnised in these financial statements.
e Re80urces expended and basis of allocation of costs
Resources expended are accounted for on an aLLruals basi5 and have I￿en classifled under headings that aggregate
all costs related to the category. Where costs cannot be directly attributed to parbcular headings they have been
alFocat&J to activtties on a basis consistent vllth use of resources. The irrecoverable value added tsx is included with
the item of expense to which it relates.
f Expenditure on charitsble activities
These represenl the Costs of providing the medical arxl training seNices of the hospital and its clinics including both
direct expeThJibJre and the a5scciatgJ supFx)rt costs.
g Governance costs
These comprise costs attributable to the overall manaJement of the Charitvs affairs and compliance Y￿th
conststutional and sLalutory iequiRfflenls.
h Cash flow statement exemptlon
The Charity has taken advantage of the exemption in FRS 102 from preparing a statement of cash Ilows, on the basis
that tt is a qualfying entity.
l Rentsls
The costs in respect of rentals are Charged to the Statement of FinarKial Activibes on a straight line basis over the
contract period.
J Cash
Cash includes cash, lime dep)sits, and ￿[tifiCates of deFosit, in aldition to cash at bank and in hand held in current
accounts with UK and Palestinian Banks.
17

**St. John of Jerusalem Eye Hospital Notes to the Financial Statements For the year ended 31 December 2024** 

. sc **Principal accounting policies (continued)** ye **e** S) v4 **k Pension and other end of service costs** aay pe + \* + Phe The amount charged in the Statement of Financial Activities in respect of pension costs is the contributions payable in the year on an accruals basis in respect of defined contribution and money purchase pension arrangements. Other end of service benefits are accrued as earned on an undiscounted basis. i= **Taxation** The Charity is entitled to certain tax exemptions on income and gains from Investments, and surpluses on any trading activities carried ~*~ _ " p o> ie P-wu —i ; hens it + _= Sale on in furtherance of its primary objectives, if these gains and surpluses are applied solely for charitable purposes. dts lina aT eased precipreapea **m Tangible assets and depreciation** Cost of tangible assets includes the original purchase price of the asset and the costs attributable to bringing the asset to its working condition for its intended use. ' mencireeered _t , as tires7 . ~—A A -& PO eeP " ee Donated fixed assets are brought Into account at an estimate of their market value at the time of acquisition and, thereafter, pe Neo See) Late FS 7ASeee ae ee al a depreciated on the bases set out below. The costs of minor additions to fixed assets under £500 are expensed in the year in which they are incurred. Impairment reviews are carried out if there Is an indication that the recoverable amount of an asset is below its net book value. ‘e oe Saat) cso Ree eer rare Adc, eet Depreciation on fixed assets is provided at rates estimated to write ott the cost, less estimated residual value of each asset, over its i = 6 5 ha ee are Le yieer yt ; p> ee . ' expected useful life on a straight line basis, as follows: Buildings • 2.5% per annum Building improvements -10% per annum Medical equipment aR “yi • 15% per annum -_ Other Assets ae Motor vehicles • 20% per annum Other equipment • 20% per annum Fixtures and fittings Sad ts i. • 6% per annum : Computer equipment JOie ate • 33% per annum ae : The appropriateness of the estimated useful lives of assets are regularly reviewed. On disposal of an item of tangible assets, the difference between the disposal proceeds and Its carrying amount is recognised in other D econ > ieee hospital Income in note 4. Sa Ma Fi Symmes nl ge aesipeter tg] Bice weyAsta **n Funds** 2 Restricted funds are funds which are subject to specific conditions imposed by the donors. Unrestricted funds are generally available for the Charity to carry out its charitable objectives. General reserves are unrestricted funds available to be used at the discretion of the Board of Trustees for the furtherance of the charitable objectives of the Charity and which have not been designated for any other purpose. Transfers between funds represent tangible assets purchased with restricted donations and used for hospital operations. en See ane = r . ala, ahaa ‘ Com ~ ican ar iy: Agus S **o Financial Instruments** Sima, bey The charity only enters into basic financial instrument transactions and applies section 11 and 12 of FRS 102 in respect of these financial instruments. PB fe tuna = 08h. ee el se eK ae Ee Financial assets and liabilities are recognised In the Balance Sheet when the charity becomes a party to the contractual provisions of the instrument. The net amount is reported In the Balance Sheet when there is a legally enforceable right to set off the recognised Financial assets amounts and there is an intention to se ie* is HeeLd é le on a net basis or to realise the asset and settle the liability simultaneously. re) i= A .Neen~ ae ry a Basic financial assets, including trade and other debtors and cash and bank balances are Initially recognised at transaction price. Such assets are subsequently carried at amortised cost using the effective interest method. At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows. The impairment loss is recognised in profit or loss. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is hat = aa = yh oa 1 Pee) ae ; a s ~ recognised in profit or loss. rs kan+ a ard a) ys Tov a : Kel, ee =, “x Other financial assets, including investments are initially measured at fair value, which is normally the transaction price. Such assets Sefe afee om; & e aoe in i r = a ers “as “ - =| > & +> are subsequently carried at fair value and the changes in fair value are recognised In profit or loss. Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) pak a, Le - oy ; ne oe th Hult “erin AA. “ee at sir substantially all the risks and rewards of the ownership of the asset are transferred to another party. Gre RPI RE KTR (asa, be 

et **18** 

**18** 



St. John of Jerusalem Eye Hospital Notes to the Financial Statements For the year ended 31 December 2024 

## **Financial Instruments (continued)** 

## Financial liabilities 

Basic financial liabilities, including trade and other creditors initially recognised at transaction price. Such liabilities are subsequently carried at amortised cost using the effective Interest rate method. 

Trade creditors are obligations to pay for goods or services that have been acquired In the ordinary course of business from suppliers. Creditors are classified as current liabilities If payment is due within one year or less. If not, they are presented as non-current liabilities. Financial liabilities are derecognised when the liability is extinguished, that Is when the contractual obligation is discharged, cancelled or expires. 

## **p Impairment of non-financial assets** 

At each balance sheet date non-financial assets are assessed to determine whether there is an indication that the asset may be impaired. If there is such an indication the recoverable amount of the asset is compared to the carrying amount of the asset. The recoverable amount of the asset is the higher of the fair value less costs to sell and value in use. Value in use is defined as the present value of the future cash flows before interest and tax obtainable as a result of the asset's continued use. These cash flows are discounted using a pre-tax discount rate that represents the current market risk-free rate and the risks inherent in the asset. If the recoverable amount of the asset is estimated to be lower than the carrying amount, the cal **i** ')' lig amount is reduced to its recoverable amount. An impairment loss is recognised in profit or loss. 

If an impairment loss is subsequently reversed, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but only to the extent that the revised carrying omount does not exceed the carrying amount that woul dhave been determined (net of depreciation or amortisation) had no impairment loss ben recognised in the prior periods. A reversal of an impairment loss is recognised in profit or loss. 

## **q Judgements and estimates** 

The preparation of the financial statements In conformity with generally accepted accounting principles requires the use of judgements and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenditure during the reporting period. Although these amounts are based on Trustees' best estimates of the amount, events or actions may mean thal actual results ultimately differ from those estimates, and these differences may be material. The 

period in which the change takes place if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. 

The Charity provides against receivables by making estimates based on experience regarding the level of provision required _to_ account for potentially uncollectible receivables. 

As at 31 December 2024 and 31 December 2023, the Company has accounted for an Impairment loss provision of £1,362k covering the hospital building, medical and other equipment and inventory In the Gaza branch. The war in Gaza started on the 7th October 2023, when Hamas militants attacked southern parts of Israel. The Israeli military responded with massive air strikes on almost all parts of the Gaza Strip which **was** later followed by a land incursion on nor111ern and southern parts of the Strip. Gaza staff were given clear orders by the Israeli authorities to evacuate the hospital on the second day of the _war_ and, since then, the hospital has not been functional. Although the hospital building was not directly struck, it has sustained some considerable collateral damage as a result of the hostilities. Much of the furniture and equipment and inventory have either been damaged or removed. Accordingly, Iha Company has recorded a full 100% impairment loss provision against the net book value of these assets. As the building has remained to be one of the few standing buildings in the neighbourhood, the Trustees believe that the building still has an intrinsic value. However, it Is clear, and after taking professional advice, based on a value in use basis assessment that an Impairment loss provision should be recorded, and this has been accounted for at 90% of the net book value of the asset. 

## **2 Legal status of the Charity** 

The Charity is a company limited by guarantee and has no share capital (Company No.3867950 and Charity No. 1080185) and has a registered Office at 4 Charterhouse Mews, London, EC1 M 688. The liability of each member in the event of winding up is limited to £10. 

The Company owns two £1 shares being all the issued shares In The St. John of Jerusalem Eye Hospital (Palestine) limited (company number: 6365210), which has not traded since incorporation. 

|**3**|Income from donations and legacies|Unrestricted|**Restricted**|2024|Unrestricted|Restricted|2023|
|---|---|---|---|---|---|---|---|
|||£'000|£'000|£'000|£'000|£'000|£'000|
||Donations|47|2,455|2,502|23|2,208|2,231|
||Donations in kind||||14||14|
|||47|2,455|2,502|37|2,208|**2,245**|



**19** 



John of Jenmalem Eye Hoswtal
Notes to the Financial StateTr*nts
Forthe yearended 31 D¢G¢mber2024
4 Income from Charitable ictNdi85
24
rTr)o
Tijlal
Totsl
OiJtpatienlinoJm8
Surgral income
Less." Pa118nl Rd*f
81ient R￿3￿# Ino
Othw Hospitd intsjmg
367
357
578
922
325
Palenl Rdief reFKesents ¥utk%KJth ex￿p￿0[￿ to u)¥er the Va￿ ￿ me0K￿ servw reThJerèJ pay￿￿nt LS waw&1 by the CmpaTTry ￿ere
fuThling is not aValab￿ fram the ￿leVant whefe Ik •ts we Lmat4e to P4rf tjthce AU of the *Mi¥e income wrises
unrestiictaj funds.
5 Total £xpendnure
a Resources expended
Costs of
Costs of
acbvibe¥ and oth¢reo81# al￿ othercosts Totsl
2023
2024
23
2024
£'ODO
Tol
)23
Personnel costs Inrts 61
costs
stabl￿h￿entO}stS
Depfeciatiffl Inote 71
Imparmenl
Offi[* 8x￿[￿&S
Travel and Su￿'s￿n
Auditor5, remUr￿[8ti
Other profoSs￿￿& f&5
Other ¢￿ts
Finance costs
FOre￿n èxchange drffwBnces
Grant eXpe￿lit￿re
1,113
233
657
128
233
73
138
51
128
1B
18
16
16
17
17
17
13
28
13
1241
76
799
1241
17
17
Sup
Cfsts I￿lUd￿ abry4e
19)
Totd rwurces exwnded in 2024of£2,515,fpJ)12023, £3,926,￿) £3t9,OCQ12023. £2.626,CWltr un￿tn(1ed funds
d £2,1%.(JJ)12023, £1,JJJ,OO0ft*r&lrKt￿ fvThtsl.
Supwt costs
e￿O￿ne
Establ￿￿Mentct￿ts
Depreoalion
£'ODO
37
14
18
27
Finan￿ cc6
n exch
e dfvenL
24
190

St. John of Jeru8alern Eye Hospital
Notes to the Financial Statements
For the year ended 31 December 2024
5 Total rgsources expended (continuad)
2024
2023
b Auditors, remuneration {excluding value added tax):
Extsmal Audlt
Other services provided by external auditors
14,418
14,263
7,231
14,418
6 Employee inforniation
a Staff numbers
The avera9e monlhly number of employees, inclLKling part time staff, anatysed by functh)n was:
2024
Number
51
14
2023
Number
57
16
Medical and nursing
Support Setv￿eS
Administration
70
78
b Staff costs
2024
£'ooo
1,070
41
2023
£'ooo
1,346
59
Wages and salari8S
Pension costs
Other relaled costs- net
1,113
1,406
c Emoluments of employees
The number of employees those emo[un￿t$ Isalarias and b8neffts in ￿nd) fell within the folbying bands Y￿re..
2024
Number
2023
Number
£60,TrJ1- £70,C4JO
d Remunerntion rec•iv•d by kwi managémént pl￿)n
This represents salaries and other benefits re￿iVed by ￿n￿r management personnel ￿thin their course of
employmenl in managing tne daily operations of the charity. The arN)unt ￿eNed by 3 slaff nEmbers12023'. 31
an￿Unted to £131,00012023.' £144,000).
21

&. John of ￿rusaleM Eye Ho$pitaF
Notes to the Financial Statements
For the year ended 31 Decemhr 2024
7 T*nGibl• ass•tA
8ulldlngs &
Medlca
lrnprovwnents Equipment
rooo
3,740
Ass
Total
£'ooo
Cost
Balance al 1si Januay 2024
A&J￿OnS
EK¢h￿9¢ differences
3,789
519
10
675
45
8*ance * 31st De￿mbor 2Q24
4275
1018
535
Awimulated Depreclatlon and lrwlrn￿nt
ance al1sl January 2024
Charge for the year
Exchange differenGes
1,320
93
16
3.654
41
42
138
84￿ce at 31st December 2024
3.737
492
Nd 8¢)ok Valu•
At315t Decemter 2024
281
Al 31si 0e¢emtor 2023
135
37
0thorAss8ts C￿PASe SJmitJre aNJ ftxbjres, wnputh, bwluctes, offtt eqiiwwL
8 Debtors
2024
rooo
2023
rooo
Arnounts falling duè within cffle y
Trade debtors
Donati￿$ receivable
Pr@Payrn8nts aThJ inf£A
Intercom
an
balance
220
821
22
20
911
2.377
1.974
2.704
Tradè dÈbtors of £220,LhXI12023. £307,IYJOI indud* a prov￿¢¢n of £9S).I1￿I2023, £950,tXX)l ¥Ja¥tst Pdestsnian Authonty ¢ebt
1nt8ro)mp￿Y inc*Jd85 cth the (Amutal firThth8 dmnd ￿ are ￿t￿estfre&
9 Cr¢dltor¥
307
Amounts falling du• within on• y
2024
rooo
2023
Trade cr&f¢ors
Taxation and so¢il security
Accruals
Retirement t¢n¢ffts
255
1,302
374
1,236
1.870
352
1,619
Accrued retirement benefits mainty represent ￿oUnts payable line with relewl law when staff leave the gnpbyment ol
the Company. Such amounts are &cruaJ when eam&J. b&*Y on cutTentMc￿th1Y s*ries *)d peri&ts ofseNce. Ajg)
induded in the balan￿ ¥e pro¥Adefil Sch￿eS.

St John of Jerusalem Eye Hospital Notes to the Financial Statements For the year ended 31 December 2024 

## 10 Restricted income funds 

|||||**Transfers -**|||
|---|---|---|---|---|---|---|
|||||**Purchase of**|**Purchase of**||
||**At 1st**<br>**January**|**Incoming**<br>**Resources**|**Costs of**<br>**charitable**|**Tangible**<br>**Fixed**||**At 31**<br>**December**|
||**2024**||**activities**|**Assets**||2024|
|QFFD Fund<br>Johanniter (JIA) Fund<br>£'000<br>£'000<br>£'000<br>£'000<br>235<br>1,024<br>(1,024)<br>(235)<br>172<br>64<br>(105)<br>(131)<br>£'000<br>——<br>eS<br>lee<br>ee|||||||
|ESCRS Fund||86|(78)|||8|
|Arab Funds<br>IMC/ USAID Fund||137<br>7|(7)|(137)|(137)||
|BMZ Fund||136|(136)||||
|Orcam Fund<br>Johanniter (GFFO) Fund||**6**<br>193|(6)<br>(193)||||
|Fred Hollows Foundation Fund<br>USA Priory Fund<br>————|559<br>(559)<br>**513**<br>**243**<br>(88)<br>(627)<br>**920**<br>**2,455**<br>**(2,196)**<br>**(1,130)**<br>~~ee~~||||(627)<br>=|**41**<br>**49**|
|||||**Transfers•**|||
|||||**Purchase of**|||
||**Al 1 st**<br>**January**|**lnGoming**<br>**Resources**|**Costs of**<br>**charitable**|**Tangible**<br>**Fixed**||**At31**<br>**December**|
||**2023**||**activities**|**Assets**||**2023**|
|QFFD Fund<br>Johanntter (JIA) Fund<br>**£'000**<br>**£'000**<br>**£'000**<br>**£'000**<br>668<br>(255)<br>(178)<br>187<br>(15)<br>**£'000**<br>235<br>172<br>ee|||||||
|ESCRS Fund|70|89|**(159)**||||
|IMC / USAID Fund||53|(53)||||
|BMZ Fund<br>Orcam Fund|117|421<br>6|(538)<br>(6)||||
|Fled Hollows Foundation Fund||269|(269)||||
|USA Priory Fund||513||||513|
|Gaza Emergency Appeal Fund<br>Poor Patient Fund|3|**1**<br>1|(1)<br>(4)||||
||**190**|**2;208**|**(1,300)**|**(178)**||**920**|



- Qatar Fund For Development (QFFO) contributed towards performing surgeries including the purchase of medical supplies and equipment needed for operations. 

- Johanntter International Assistance -JIA Fund contributed towards the purchase of medical supplies and equipment. 

- ESCRS Fund: The European Society of Cataract and Refractive Surgeons contributed towards the performance of cataract surgeries. Arab Funds contributed towards establishing the new Nablus hospital. 

- IMC /USAID Fund contributed towards expanding the level of operations within the Gaza branch especially for needy patients 

- BMZ Fund project contributed towards expanding the level of operations within the Gaza branch through the introduction of a Diabetic Retinopathy screening and epidemiological research components, 

- Orcam Fund contributed towards assisting visually impaired patients. 

- Johanniter (GFFO) Fund contributed towards expanding our services within the Occupied Palestinian Territories. 

- Fred Hollows Foundation Fund: contributed towards expanding the level of services within Gaza. 

- USA Priory Fund: contributed towards establishing and equipping the new hospital in Nablus and purchasing of a new laser machine for Gaza. 

## 11 **Unrestricted income funds** 

|**2024**<br>**2023**|
|---|
|Opening balance<br>**£'000**<br>3,599<br>**£'000**<br>5,025<br>eres|
|Income<br>710<br>1,022|
|Expenditure<br>(319)<br>(2,626)|
|Transfer from restricted funds<br>Total Unrestricted Funds<br>1,130<br>**5,120**<br>178<br>**3,599**<br>**e**e<br>Oe<br>S<br>EE<br>e—<br>SS|



Transfers represent amounts released from restricted funds for the purchase of tangible assets. 

12 Total charity funds 

|UnrestrictedUnrestricted<br>Restricted<br>Restricted<br>Total<br>Total|
|---|
|Funds<br>Funds<br>Analysis by type of asset and liability<br>2024<br>2023<br>Funds<br>2024<br>Funds<br>2023<br>Funds<br>2024<br>Funds<br>2023|
|£'000<br>£'000<br>Tangible assets<br>3,170<br>2,592<br>£'000<br>£'000<br>£'000<br>3,170<br>£'000<br>2,592<br>ee<br>ee en A<br>ee<br>ee<br>we<br>eee<br>||
|Net current assets<br>1.950<br>1,007<br>49<br>920<br>1,999<br>1,927|
|5,120<br>**3,599**<br>49<br>920<br>5,169<br>**4,519**<br>ee<br>ee~~e~~<br>~~ae~~<br>SE<br>ee<br>~~ee~~<br>~~eee~~|



23 



SL John of Jerusalem Eye Hospltal
Nth¥ to the FinallGlal Statements
Forthe yurended 31 Decents2024
13 Try¥tee8' renwnera
The Trnstees re￿Ne no rthnerab'on.
l expenses inuJrr8d by the Trustees werè ty Ihe p¥effl l*aftsb￿ thmpaw.
14 Financial kn$tmmÈnts
The Company has laken ajvantage oltrie exernptvJn whith is aVatiab￿ undw FRS 102 1.121 el,
Irdating to sec*ons11 and 12 ofthe stsndwdl as a wholtyowneA notto disdc& the
following..
Cate9ofEe5 offinancad instrunmts
Items ol income, expenses, gwns or k)sses relating ID financAa inslnjmenty a￿j
Expesure to and m￿ageMent of financial risks
Full disclosure in relation to finan(ial instruwits 15 the ¢￿St￿dabJ siatements of
Sl. John ofJerus*m Eye Hospita Group.
15 Related partles trdnsactlons
The sole memberofthe Company, gnce 31 Marc* 2011. is St &)hn ofJerusakni Hosptsl Grwp,
which appoints the Board of DirectO￿￿$tees ofthe Cornpany.
During the ye￿, the Chamian oflhe Charity, Sw And￿ Cash. was the chamw for St th)hn of
J8rusalem Eye Hospiu Gnjup.
The Company owns kn £1 shares bein9 all the i%sued shaw in The St John Eye Hwita
(Palestino) ￿rnited Icomwy number. 8365210). whK* h&8 nottr*led since in0)ry￿rati￿.
16 Contractual & designated obligations
In 2023: the Board approved the plan of rebcating the Anabts cfinic Ihe e5tsblishrrEnlof a new da
hospttsl in Nablus Crty. The tota eostforthis propct ts estimated at circa £3m including the costto
wrolase the propety. The project funded ty The Priory in the USA ofthe Order ofStJohn,The Dwrd
d Molly Foundation, The Australian Deparb7)entof Fffeign Affirs and Traje IDFATI, *d Ihe
Group's general reseNes est'mated a1£12m.The proie¢twas compW in March 2025.
24